Elevance Health vs Eli Lilly stock
Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.
Elevance Health is cheaper for its profits. Eli Lilly is more profitable, grows faster and has less debt.
Side by side
| Elevance Health | Eli Lilly | |
|---|---|---|
| $85.2 billion | $1.20 trillion | |
| 2.8% | 31.7% | |
| +9.5% | +21.6% | |
| 15.1× | 58.1× | |
| 2.3 years | 1.1 years | |
| 8.7% | 34.8% | |
| 1.7% | 0.6% |
How we compare
Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.
More comparisons: Elevance Health vs UnitedHealth · Elevance Health vs AbbVie · Elevance Health vs The Cigna Group · Eli Lilly vs Gilead Sciences · Eli Lilly vs GSK · Eli Lilly vs Intuitive Surgical · Eli Lilly vs Johnson & Johnson

